01 Industry overview
The longevity clinic industry at a glance
The global longevity clinic market reached $5.35 billion in 2025, with North America the largest regional market and Asia-Pacific the fastest-growing region.
- $5.35B[3]
- Global market size, 2025
- 12.2%[3]
- Forecast CAGR, 2025–2030
- 800[12]
- U.S. longevity clinics, 2026
- $30.0B[13]
- Alternative 2026 market estimate
- Market size
- The Business Research Company estimates the global longevity clinic market at $5.35 billion in 2025. A separate 2026 estimate places the market at $30.0 billion, highlighting the lack of a standardized market boundary between longevity clinics, concierge medicine, regenerative medicine and wellness services.[3][13]
- Forecast & CAGR
- The Business Research Company forecasts growth from $5.35 billion in 2025 to $9.55 billion in 2030, implying a 12.2% CAGR. Healthcare Industry Insights projects a 10.6% CAGR from 2026 to 2035, reaching $74.3 billion.[3][13]
- Market share & regions
- North America was the largest regional market in 2025, while Asia-Pacific was identified as the fastest-growing region. One 2025 industry estimate also reports that diagnostic testing and biomarker analytics represented approximately 48.0% of global longevity clinic revenue.[3][13]
- Segmentation
- Longevity clinics typically combine diagnostic testing, biomarker analytics, physician consultations, nutrition and lifestyle coaching, hormone or peptide programs, regenerative medicine and wellness therapies. Healthcare Industry Insights identifies diagnostic testing and biomarker analytics as the largest offering category, at approximately 48.0% of the market in 2025.[13][3]
- Key players & concentration
- The U.S. market is fragmented across independent practices, concierge-care groups, digital health providers, medical-spa platforms and clinic franchises; KeyBank cites approximately 800 longevity-focused clinics operating in the United States in 2026. Publicly visible operators include Fountain Life, Human Longevity, Next Health, Serotonin Centers and Humanaut Health, but no reliable source identified a defensible company market-share ranking.[12][14]
- Pricing
- Published membership prices vary widely by service mix and positioning. A 2026 review of eight providers found annual prices ranging from $1,987 to $35,000, with a median of $9,750; another review of 19 practices found entry pricing from $99 per month to $20,000 per year.[10][11]
- Trends, drivers & challenges
- Growth is being driven by demand for preventive and personalized care, advanced diagnostics, AI-supported health assessments and recurring membership models. Key challenges include limited evidence for many anti-aging interventions, blurred boundaries between medical care and wellness services, affordability and regulatory uncertainty around compounded peptides.[3][15][16]
- Consumer behavior & competition
- Consumers increasingly purchase bundled assessments, repeat biomarker testing, coaching and access to prescription or wellness interventions through annual memberships. Competition spans physician-led clinics, concierge medicine, telehealth and medical-spa platforms; published annual prices range from $1,987 to $35,000, indicating strong differentiation by clinical depth, diagnostics and brand positioning.[10][3]
- M&A
- Consolidation remains active but fragmented. In July 2026, First Choice Healthcare Solutions announced a proposed business combination with Westin Acquisition Corp. at an approximately $650 million pro forma enterprise value; in April 2025, Longevity Health Holdings announced a merger with 20/20 Biolabs expected to increase anticipated 2025 revenue from approximately $3–4 million to $7–8 million.[14]
- Regulation
- In the United States, clinics using compounded peptides face FDA scrutiny: the FDA identifies potential immunogenicity, impurity and limited-safety-data concerns for substances including BPC-157 and CJC-1295. Health-related advertising is also subject to FTC substantiation requirements, which generally require competent and reliable scientific evidence for benefit claims.[15][16]
- Latest news
- In November 2026, Serotonin Active announced that its first physician-led longevity clinic would open inside a New York Sports Club in Manhattan, illustrating the sector’s move toward partnerships with gyms and existing consumer-health venues. Humanaut Health also announced six additional franchise and corporate locations in the United States and Mexico in November 2026.[14]
02 Ranking
Top 10 Companies in the Longevity Clinic Industry
The leading companies in the longevity clinic industry, ranked on market impact, performance, momentum, innovation and brand popularity.
Updated November 20, 2026 · Next review December 20, 2026
Clinique La Prairie stands out for health resorts and Longevity Hubs because it runs them across Europe, Asia and the Middle East, while Next Health is the pick for clinic networks since its directory lists 25 locations across the United States, Canada and Dubai.
Ranked by Overall score · How we score ↓
Editor's top 3 picks
Where to start, by need.
#1 Overall · Leader in longevity resorts and hubs
Clinique La Prairie
CH
Ranked #1 · 9.8 · Longevity resorts and hubs
Why we picked it: It operates Longevity Hubs and health resorts across multiple regions, including Europe, Asia, and the Middle East.
Leader in longevity clinic networks
Next Health
US
Ranked #2 · 9.6 · Longevity clinic networks
Why we picked it: It builds scale through a multi-country directory footprint spanning the United States, Canada, and Dubai.
Leader in precision-medicine diagnostics clinics
Human Longevity
US
Ranked #4 · 8.7 · Precision-medicine diagnostics clinics
Why we picked it: Its footprint centers on two precision-medicine clinic locations in San Diego and South San Francisco.
Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.
Full ranking
| # | Company | Overall ↓ | Impact | Performance | Momentum | Innovation | Company snapshot |
|---|---|---|---|---|---|---|---|
| 1 | Clinique La Prairie Longevity resorts and hubs · CH | 9.8 | 9.9 | 9.9 | 9.3 | 9.9 | |
Company snapshot · Clinique La Prairie · Data as of November 20, 2026 Runs health resorts and Longevity Hubs across Europe, Asia and the Middle East.[17]
| |||||||
| 2 | Next Health Longevity clinic networks · US | 9.6 | 9.9 | 9.6 | 9.9 | 8.9 | |
Company snapshot · Next Health · Data as of November 20, 2026 Its directory lists 25 locations across the United States, Canada and Dubai.[18]
| |||||||
| 3 | SHA Wellness Clinic Longevity resorts and hubs · ES | 9.0 | 8.8 | 9.6 | 8.8 | 8.9 | |
Company snapshot · SHA Wellness Clinic · Data as of November 20, 2026 Operates SHA destinations in Spain, Mexico and the United Arab Emirates.[19]
| |||||||
| 4 | Human Longevity Precision-medicine diagnostics clinics · US | 8.7 | 8.8 | 8.8 | 8.2 | 8.9 | |
Company snapshot · Human Longevity · Data as of November 20, 2026 Operates precision-medicine clinics in San Diego and South San Francisco.[20]
| |||||||
| 5 | Fountain Life Longevity clinic networks · US | 8.7 | 9.9 | 8.5 | 7.6 | 8.0 | |
Company snapshot · Fountain Life · Data as of November 20, 2026 Operates longevity centers in New York, Naples, Orlando, Dallas and Houston.[21]
| |||||||
| 6 | Buchinger Wilhelmi Therapeutic fasting and integrative longevity clinics · DE | 8.5 | 8.8 | 8.8 | 8.2 | 8.0 | |
Company snapshot · Buchinger Wilhelmi · Data as of November 20, 2026 Operates clinics at Lake Constance, Marbella and the Côte d’Azur.[22]
| |||||||
| 7 | Lanserhof Medical wellness and longevity resorts · AT | 8.4 | 9.9 | 7.0 | 7.0 | 8.9 | |
Company snapshot · Lanserhof · Data as of November 20, 2026 Operates medical wellness locations including Lans, Tegernsee, Sylt and London.[23]
| |||||||
| 8 | Pritikin Longevity Center Residential lifestyle medicine and longevity programs · US | 8.2 | 8.8 | 8.8 | 7.6 | 7.0 | |
Company snapshot · Pritikin Longevity Center · Data as of November 20, 2026 Runs a physician-led residential health program at its 800-acre Miami resort.[24]
| |||||||
| 9 | YEARS Preventive diagnostics and longevity medicine, Berlin · DE | 8.0 | 7.0 | 8.8 | 8.2 | 8.9 | |
Company snapshot · YEARS · Data as of November 20, 2026 Runs a physician-led Berlin clinic offering whole-body MRI and up to 230 biomarkers.[25]
| |||||||
| 10 | Chi Longevity Precision longevity medicine, Singapore · SG | 7.7 | 7.8 | 8.8 | 7.1 | 7.0 | |
Company snapshot · Chi Longevity · Data as of November 20, 2026 Operates a medically licensed longevity clinic at Four Seasons Hotel Singapore.[26]
| |||||||
How we score
- Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
- Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
- Momentum (20%): growth trajectory and future potential.
- Innovation (15%): R&D intensity and how technologically advanced the company is.
Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.
Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.
Cadence Recalculated when new figures are published; next review December 20, 2026.
Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.
Cite this ranking
APA
Samuel Norberg. (2026, November 20). Top 10 companies in the longevity clinic industry. In Longevity Clinic Industry Statistics. Gitnux. https://gitnux.org/longevity-clinic-industry-statistics/#top-companies
Verified U.S. longevity practices by practice type
Hybrid — medical practice holds the largest share at 40.6%.
03 Trends & forecasts
Top 10 Longevity Clinic Industry Trends & Forecasts 2027
What is changing in the longevity clinic industry, with the evidence behind each trend and a forecast for 2027.
Forecasts were generated by an AI model from the cited evidence. They are estimates, not guarantees.
01Market growth remains double-digit
High confidenceThe Business Research Company estimates the global longevity clinic market at $5.35 billion in 2025 and forecasts $9.55 billion by 2030, equivalent to a 12.2% CAGR. North America was the largest regional market in 2025, while Asia-Pacific was the fastest-growing region.[3]
Forecast 2027: The market should continue expanding at roughly 10%–12% in 2027, with North America retaining leadership and Asia-Pacific delivering the fastest site and membership growth. Market estimates will remain wide because clinic, concierge, regenerative-medicine and wellness boundaries are not standardized.
02Diagnostics remain the commercial anchor
High confidenceLongevity clinics increasingly organize their offering around biomarker panels, imaging and biological-age assessments. A 2026 census of 3,549 verified U.S. practices found blood testing listed by 50.4% of practices and biomarker panels by 15.1%, while a separate survey reported that 51% of clinics viewed pace of aging as a reliable tracking marker.[5][8]
Forecast 2027: In 2027, diagnostic testing will remain the primary entry product and the main justification for recurring care. Operators will emphasize repeatable panels, actionable risk stratification and longitudinal trend reports rather than one-time testing alone.
03AI-enabled personalization expands
High confidenceThe Business Research Company identifies AI-enabled personalized longevity assessments as a major market trend. Research published in 2026 describes AI applications in biological-age assessment, predictive analytics, diagnostics and remote monitoring, while noting the need for governance, transparency and bias controls.[3][27]
Forecast 2027: By 2027, AI will be used more widely for test interpretation, risk prioritization, patient monitoring and individualized coaching, but physician review will remain necessary for diagnosis and treatment decisions. Clinics with proprietary longitudinal data should gain a competitive advantage.
04Membership models broaden downward
High confidencePublished 2026 prices show a wide cash-pay market: annual longevity memberships ranged from $1,987 to $35,000 across eight providers, with a median of $9,750. A separate review of 19 practices found entry prices below $7,500 annually for 14 practices, including monthly plans near $139–$199.[10][11]
Forecast 2027: In 2027, the market should separate more clearly into lower-cost monitoring and coaching memberships, mid-priced physician-guided programs, and premium diagnostic packages. Tiered subscriptions and monthly payment options will be used to expand beyond affluent early adopters without eliminating high-end services.
05Metabolic care drives patient acquisition
High confidenceA 2026 U.S. practice census found medical weight loss—largely GLP-1 prescribing—to be the most common offering in American longevity medicine. The same research found that 31% of verified practices marketed hormones, peptides or infusions without listing a diagnostic service, showing how metabolic and intervention-led offerings are pulling consumers into the category.[5]
Forecast 2027: GLP-1-linked weight management, body-composition monitoring and metabolic coaching will remain major acquisition channels in 2027. Clinics will increasingly use these services as recurring-care gateways, then cross-sell diagnostics, exercise, nutrition and cardiovascular risk management.
06Peptide use faces tighter scrutiny
High confidenceThe FDA identifies potential immunogenicity, impurity and active-ingredient characterization concerns for compounded BPC-157 and CJC-1295; it also states that available safety information for some substances is limited. These concerns directly affect clinics offering compounded peptide protocols.[15]
Forecast 2027: In 2027, clinics will face greater pressure to document prescribing rationale, sourcing, informed consent and adverse-event monitoring for peptide programs. Some operators will shift toward FDA-approved medicines and clearly labeled wellness services, while higher-risk peptide claims will become a compliance and reputational liability.
07Evidence-based positioning gains value
High confidenceThe FTC requires health-related advertising claims to be truthful, not misleading and supported by competent and reliable scientific evidence. The agency states that randomized controlled human trials are generally the most reliable support for health-benefit claims and has pursued more than 200 cases involving misleading health advertising since 1998.[16]
Forecast 2027: In 2027, credible operators will differentiate through clinical protocols, explicit uncertainty statements, outcome tracking and physician oversight. Marketing centered on broad anti-aging promises, testimonials or biological-age claims without adequate substantiation will face increasing legal and platform risk.
08Fitness venues become distribution channels
High confidenceIn September 2026, Hone Health partnered with Bodybar Pilates to offer biomarker testing and physician-guided care across more than 40 studios. Other 2026 partnerships connected longevity services with New York Sports Club and UFC GYM, showing that fitness operators can distribute care without building full medical infrastructure themselves.[28][29]
Forecast 2027: Gym, Pilates and recovery-platform partnerships should accelerate in 2027, particularly for testing, weight management, recovery and coaching. These channels will lower customer-acquisition costs and make longevity services more routine, while clinical governance will remain the key execution challenge.
09Franchising accelerates physical expansion
High confidenceUltimate Longevity Center announced in November 2026 that it had sold more than 300 U.S. territories and planned to open its first centers in January 2027. Humanaut Health also announced six additional U.S. and Mexico locations, expanding from three planned or existing sites to nine.[30][31]
Forecast 2027: 2027 should bring a sharp increase in branded franchise and multi-site openings. Franchisors will standardize diagnostics, clinician training, supply chains and membership software, but uneven execution across locations may increase scrutiny of quality and medical-director arrangements.
10Private equity pushes consolidation
High confidenceKeyBank reported approximately 800 longevity-focused clinics operating in the United States in 2026 and identified recent private-equity investments in concierge and longevity platforms, including Griffin Concierge Medical and Novellum Longevity. The report characterizes the sector as fragmented, with blurred boundaries between concierge medicine, aesthetics and longevity care.[12]
Forecast 2027: In 2027, investors will favor platforms that combine recurring memberships, standardized clinical operations and multiple locations. Consolidation will likely remain selective rather than dominant because definitions, reimbursement models and clinic-level economics are still inconsistent.
04 Statistics
Market Intelligence
The market intelligence view anchors on global size at $5.35 billion in 2025 and shows how directory-based counts reach 1,263 organizations and 1,109 clinic locations in November 2026.
Market size and service revenue in the longevity clinic industry
- Approximately $500–750 million was the U.S. longevity-clinic market size in 2024, based on public data from leading brands, city-level scrapes and third-party estimates.[1]
- $3.88 billion was the estimated U.S. longevity-clinics market size in 2025, using the study’s definition of clinics offering check-ups, advanced tests and personalized health plans.[2]
- $5.35 billion was the global longevity clinic market size in 2025, covering preventive care, diagnostics, personalized medicine, wellness programs, anti-aging treatments and related services.[3]
Growth forecasts for the longevity clinic industry
- The global longevity clinic market is projected to grow from $5.35 billion in 2025 to $6.02 billion in 2026, a 12.5% CAGR for 2025–2026.[3]
- The global longevity clinic market is projected to reach $9.55 billion by 2030 from $5.35 billion in 2025, implying a 12.2% CAGR during 2025–2030.[3]
- The U.S. longevity-clinics market is projected to reach $8.29 billion by 2034 from $3.88 billion in 2025, representing an 8.8% CAGR during 2025–2034.[2]
Firm counts and size structure in the longevity clinic industry
- The Longevity.io directory listed 1,263 organizations and 1,109 clinic locations in November 2026, including 778 organizations categorized as clinics.[4]
- Dedicated longevity clinics represented 17.9% of 3,549 verified U.S. longevity-medicine practices in 2026; hybrid medical practices represented 40.6% and hybrid med spas 39.6%.[5]
- 3,549 U.S. practices offering longevity medicine were verified in 2026; 634 were dedicated longevity clinics and the remainder offered longevity services within broader practices.[5]
Regional breakdown of the longevity clinic industry
- Nevada had the highest density at 2.22 verified longevity practices per 100,000 residents in 2026, followed by Arizona at 2.20 and Colorado at 1.90.[5]
- New York City had 56 verified longevity practices in 2026, followed by San Antonio with 37 and Scottsdale and Las Vegas with 31 each; figures use city limits, with New York counting all five boroughs.[5]
- California had 433 verified longevity practices in 2026, compared with 346 in Florida and 323 in Texas; counts refer to practices at their primary U.S. locations.[5]
05 Statistics
Strategy & Growth
Transaction visibility remains limited: 20 of 25 sample deals had no disclosed acquisition value through June 2026, with one completed acquisition in January 2026.
M&A and consolidation in the longevity clinic industry
- 20 of 25 transactions in the curated global longevity-industry sample had no disclosed acquisition value through June 2026.[6]
- 1 longevity-clinic acquisition was completed in January 2026 when Agentis Longevity acquired BioDesign Men’s Clinic in Florida.[7]
- 25 transactions were recorded in a curated global longevity-industry transaction sample through June 2026; the sample includes mergers, asset purchases and other structures, not only clinic acquisitions.[6]
06 Statistics
Operating Benchmarks
Benchmarks show adoption of clinical programs and data feeds, including 63% of 3,549 verified practices offering medical weight loss and 37% of 82 surveyed clinics fully integrating longevity protocols into electronic medical records.
Operating metrics used in the longevity clinic industry
- 63% of 3,549 verified U.S. longevity practices offered medical weight loss in 2026, followed by functional medicine at 57.8% and hormone-replacement therapy at 56.8%.[5]
- 37% of 82 surveyed longevity clinics fully integrated longevity protocols into electronic medical records, while 35% intended to implement integration in the future.[8]
- 65% of 82 surveyed longevity clinics integrated wearable-device data into client assessments in the 2025 Longevity Clinics Survey.[8]
07 Statistics
Pricing
Pricing dispersion is wide in 2026, with U.S. membership prices ranging from $99 per month to $20,000 per year and Canada tier pricing for Precision Longevity at CAD 3,500 to CAD 14,300.
Fees and price levels in the longevity clinic industry
- Precision Longevity listed annual memberships at CAD 3,500, CAD 5,400, CAD 7,100 and CAD 14,300 for four service tiers in Canada in July 2026.[9]
- Annual longevity-clinic prices ranged from $1,987 to $35,000 across 12 prices from eight providers checked on October 22, 2026.[10]
- Published longevity-clinic memberships ranged from $99 per month to $20,000 per year across 13 U.S. practices checked on November 13, 2026.[11]
Key questions about the longevity clinic industry
How big is the global longevity clinic market in 2025?
What growth trajectory does the market show after 2025?
Which companies lead the longevity clinic industry?
Where are technology and data integration shifting in 2026?
How fragmented is the U.S. market structure for longevity medicine practices?
What do published membership prices look like across U.S. and Canada in 2026?
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
Samuel Norberg. (2026, November 20). Longevity Clinic Industry Statistics. Gitnux. https://gitnux.org/longevity-clinic-industry-statistics
Samuel Norberg. "Longevity Clinic Industry Statistics." Gitnux, 20 Nov 2026, https://gitnux.org/longevity-clinic-industry-statistics.
Samuel Norberg. 2026. "Longevity Clinic Industry Statistics." Gitnux. https://gitnux.org/longevity-clinic-industry-statistics.
Sources & references
31 sources cited across this report
occstrategy.com
- acuitashealthanalytics.com
thebusinessresearchcompany.com
- longevity.io
whelth.com
newmarketpitch.com
- 1858partners.com
longevity.technology
2100.health
- longevityvanguard.com
pabau.com
key.com
healthcareindustryinsight.com
globenewswire.com
fda.gov
ftc.gov
- cliniquelaprairie.com
- next-health.com
- shawellness.com
humanlongevity.com
fountainlife.com
- buchinger-wilhelmi.com
- lanserhof.com
- pritikin.com
- years.co
- chilongevity.com
nature.com
athletechnews.com
streetinsider.com
prnewswire.com
- igniteitwellness.com